Verrica Pharmaceuticals Inc. (VRCA) Ownership
VRCA ownership summary
as of October 18, 2026- Institutions
- 27.1% of shares outstanding
- Insiders
- 49.00% of shares outstanding
- Shares outstanding
- 17.2M
- Float
- 12.4M shares available to trade
- Short interest
- 2.22% 196K shares short
- Days to cover
- 3.79 short interest down 3.2% vs prior month
- Institutions 27.14%
- Insiders 49.00%
- Other investors 23.86%
VRCA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Caligan Partners LP | 5.38% | 924K | $3.3M | — | June 30, 2026 |
| 2 | Cannell Capital LLC | 4.56% | 784K | $2.8M | +98,800 (+14.4%) | June 30, 2026 |
| 3 | Affinity Asset Advisors, LLC | 4.12% | 707K | $2.5M | — | June 30, 2026 |
| 4 | Velan Capital Investment Management LP | 2.75% | 472K | $1.7M | — | June 30, 2026 |
| 5 | Armistice Capital, LLC | 2.48% | 426K | $1.5M | −91,877 (−17.7%) | June 30, 2026 |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 1.63% | 281K | $1.0M | — | June 30, 2026 |
| 7 | Vanguard Capital Management, LLC | 1.63% | 279K | $1.0M | +90,552 (+48.0%) | June 30, 2026 |
| 8 | Mariner Wealth Advisors LLC | 1.21% | 207K | $744,992 | +182,686 (+744.3%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 0.80% | 138K | $496,685 | −757 (−0.5%) | June 30, 2026 |
| 10 | BlackRock Inc | 0.43% | 74K | $267,267 | +35,791 (+92.8%) | June 30, 2026 |
| 11 | Vanguard Fiduciary Trust Co | 0.41% | 70K | $252,272 | +5,072 (+7.8%) | June 30, 2026 |
| 12 | Two Sigma Investments LLC | 0.24% | 41K | $146,766 | −9,837 (−19.4%) | June 30, 2026 |
| 13 | State Street Corp | 0.17% | 29K | $103,953 | — | June 30, 2026 |
| 14 | Northern Trust Corp | 0.16% | 27K | $97,051 | −4,584 (−14.5%) | June 30, 2026 |
| 15 | Dafna Capital Management LLC | 0.14% | 24K | $85,381 | −129,962 (−84.5%) | June 30, 2026 |
| 16 | Jane Street Group LLC | 0.14% | 24K | $85,036 | −25,557 (−51.9%) | June 30, 2026 |
| 17 | Verdad Advisers, LP | 0.13% | 23K | $82,933 | +10,971 (+90.7%) | June 30, 2026 |
| 18 | Renaissance Technologies Corp | 0.13% | 22K | $78,260 | −10,591 (−32.7%) | June 30, 2026 |
| 19 | Legacy Trust | 0.10% | 17K | $59,619 | −650 (−3.8%) | June 30, 2026 |
| 20 | Fifth Third Bancorp | 0.08% | 14K | $50,330 | +14,000 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 438K shares and 8 cut 274K.
VRCA top mutual fund and ETF holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.26% | 216K | $778,120 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.35% | 61K | $218,076 | −326 (−0.5%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.18% | 32K | $113,534 | −218 (−0.7%) | September 30, 2026 |
| 4 | Fidelity Total Market Index | 0.12% | 20K | $73,690 | — | August 31, 2026 |
| 5 | Fidelity Series Total Market Index | 0.11% | 19K | $68,212 | — | August 31, 2026 |
| 6 | Fidelity Nasdaq Composite Index | 0.07% | 12K | $44,057 | — | August 31, 2026 |
| 7 | 1290 VT Micro Cap K | 0.01% | 2,195 | $7,891 | — | August 31, 2026 |
| 8 | DFA US Micro Cap I | 0.01% | 2,088 | $7,506 | — | August 31, 2026 |
| 9 | JNL/DFA US Small Cap A | 0.01% | 1,982 | $7,125 | +1,982 (0.0%) | June 30, 2026 |
| 10 | Vanguard U.S. Eq Idx £ Acc | 0.01% | 862 | $3,099 | — | August 31, 2026 |
| 11 | Avantis Total Equity Markets ETF | <0.01% | 481 | $1,729 | — | September 30, 2026 |
| 12 | Vanguard Balanced Index Inv | <0.01% | 262 | $942 | — | August 31, 2026 |
| 13 | Knights of Columbus U.S. All Cap Idx I | <0.01% | 51 | $183 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VRCA insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-25 | David Zawitz | Buy | $4.24 | 10,000 | $42,400 |
| 2025-11-25 | Jayson Rieger | Buy | $4.24 | 94,311 | $399,879 |
| 2025-11-25 | John J Kirby | Buy | $4.24 | 3,536 | $14,993 |
| 2025-11-25 | Noah L Rosenberg | Buy | $4.24 | 2,357 | $9,994 |
| 2025-11-25 | Paul B Manning | Buy | $4.24 | 1,375,380 | $5.8M |
| 2025-11-25 | Paul B Manning | Buy | $4.24 | 2,750,762 | $11.7M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VRCA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VRCA
Institutional investors own 27.1% of Verrica Pharmaceuticals's shares and insiders 49.00%. The largest holder is Caligan Partners LP with 5.38% of the shares (924K), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 8 reduced their stake in the latest filings. Short interest is 2.22% of the float, or 3.79 days of average trading volume. The share count rose 434.0% since 2017.
Related: VRCA analyst forecast, VRCA key metrics. See the VRCA stock overview for the latest quote and news.
VRCA ownership FAQ
Who owns the most Verrica Pharmaceuticals stock?
The largest shareholders of Verrica Pharmaceuticals are Caligan Partners LP (5.38%), Cannell Capital LLC (4.56%), Affinity Asset Advisors, LLC (4.12%), Velan Capital Investment Management LP (2.75%), Armistice Capital, LLC (2.48%).
What percentage of Verrica Pharmaceuticals is owned by institutions?
Institutions hold 27.1% of Verrica Pharmaceuticals's shares outstanding; insiders hold 49.00%.
Which funds own Verrica Pharmaceuticals?
The largest fund holders of Verrica Pharmaceuticals are Vanguard MStar Total Stk Mkt Idx Invest (1.26%), Fidelity Extended Market Index (0.35%), iShares Micro-Cap ETF (0.18%), Fidelity Total Market Index (0.12%), Fidelity Series Total Market Index (0.11%).
What is Verrica Pharmaceuticals's short interest?
196K shares of Verrica Pharmaceuticals were sold short, 2.22% of the float; at the average daily volume it would take 3.79 days to cover.
Are insiders buying or selling Verrica Pharmaceuticals?
Of the latest 6 reported insider transactions in Verrica Pharmaceuticals (since November 25, 2025), 6 were purchases and 0 were sales.
How many shares of Verrica Pharmaceuticals are outstanding?
Verrica Pharmaceuticals has 17.2M shares outstanding, of which 12.4M are in the public float.